Clinical Trials in New York

Showing 10841-10860 of 19,464 trials

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

NCT00306800

The purpose of this study is to compare the efficacy of Photodynamic Therapy (PDT) with methyl aminolevulinate (MAL) cream to PDT with vehicle cream, using the the LED light source Aktilite CL128, in treatment of patients with multiple actinic keratosis (sun-damaged skin) on the face and / or scalp

Actinic Keratosis

Galderma R&D80 participantsStarted Sep 2007

St. Petersburg, Florida, United States • New York, New York, United States • Rochester, New York, United States +4 more locations

No Longer Available< 1 mile

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

NCT04366830

The objectives of this intermediate-size expanded access protocol are to assess the safety and efficacy of remestemcel-L in participants with ARDS due to coronavirus infection 2019 (COVID-19).

Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19

Mesoblast International Sàrl

New York, New York, United States

COMPLETEDNA< 1 mile

Physical Telerehabilitation in Multiple Sclerosis

NCT03230903

The study aims to evaluate the efficacy of the MS HAT (Multiple Sclerosis Home Automated Telemanagement) System as an adjunct to the current standard of medical care for patients with MS (PwMS). The individual patient with MS will be the unit of analysis. For each participant, the investigators will assess the effect of Home Automated Telemanagement (HAT) on functional outcomes, levels of disablement including impairment, activity and participation, socio-behavioral parameters, and satisfaction with medical care as described below.

Multiple Sclerosis

Columbia University78 participantsStarted Oct 2016

New York, New York, United States

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Physical Telerehabilitation in Multiple Sclerosis

Find Trials by Condition in New York

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection

Model 4396 Left Ventricular (LV) Lead Chronic Performance Study

Effect of Transcranial Magnetic Stimulation on Recovery of Upper Limb Among Stroke Survivors

Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne

Personalized CRT - MPP Post Approval Study

Phase 3 Papulopustular Rosacea Study

Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance

Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris

Epiduo Pediatric Acne Study

Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

AIR Extension Study - Long-Term Safety of Alair Treated Subjects

Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris